Credit Suisse’s Ascendis Pharma A/S ASND Stock Holding History

Credit Suisse’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-8,932	Closed	-$836K	–	3060
2023 Q3	$836K	Buy	8,932 +132	+2%	+$12.3K	﹤0.01%	2392
2023 Q2	$785K	Buy	8,800 +3,800	+76%	+$331K	﹤0.01%	2548
2023 Q1	$536K	Buy	5,000 +2,221	+80%	+$254K	﹤0.01%	2709
2022 Q4	$339K	Buy	+2,779	New	+$323K	﹤0.01%	2976
2022 Q2	–	Sell	-5,900	Closed	-$692K	–	3915
2022 Q1	$692K	Buy	+5,900	New	+$683K	﹤0.01%	2785
2021 Q4	–	Sell	-1,410	Closed	-$225K	–	4497
2021 Q3	$225K	Sell	1,410 -2,904	-67%	-$397K	﹤0.01%	4192
2021 Q2	$568K	Buy	4,314 +1	+0%	+$133	﹤0.01%	3762
2021 Q1	$556K	Buy	4,313 +3	+0.1%	+$456	﹤0.01%	3702
2020 Q4	$719K	Sell	4,310 -89	-2%	-$14.7K	﹤0.01%	3585
2020 Q3	$680K	Sell	4,399 -3,591	-45%	-$516K	﹤0.01%	3199
2020 Q2	$1.18M	Buy	7,990 +1,121	+16%	+$154K	﹤0.01%	2781
2020 Q1	$774K	Sell	6,869 -8,635	-56%	-$1.12M	﹤0.01%	2852
2019 Q4	$2.16M	Buy	15,504 +11,327	+271%	+$1.26M	﹤0.01%	2540
2019 Q3	$402K	Buy	+4,177	New	+$466K	﹤0.01%	3554
2016 Q4	–	Sell	-15,031	Closed	-$302K	–	4087
2016 Q3	$302K	Sell	15,031 -999	-6%	-$16.5K	﹤0.01%	3652
2016 Q2	$212K	Buy	16,030 +6,014	+60%	+$92.7K	﹤0.01%	3845
2016 Q1	$186K	Sell	10,016 -1,204	-11%	-$21.4K	﹤0.01%	3708
2015 Q4	$205K	Buy	+11,220	New	+$197K	﹤0.01%	3876

Other funds holding ASND

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Credit Suisse's ASND Position: Q4 2023 in Review

Credit Suisse sold out of Ascendis Pharma A/S (ASND) in Q4 2023, closing a stake of 8,932 shares — an estimated $836K sold.

Credit Suisse first reported a position in ASND in Q4 2015 and held it in 18 quarters. The position peaked at $2.16M in Q4 2019. 185 funds tracked by Wall St. Rank hold ASND as of Q4 2023.

Credit Suisse reported no remaining Ascendis Pharma A/S position as of Q4 2023 after selling out during the quarter.
Credit Suisse sold 8,932 Ascendis Pharma A/S shares in Q4 2023, an estimated $836K.
Credit Suisse first reported a position in Ascendis Pharma A/S in Q4 2015 and held it in 18 quarters.
Credit Suisse's Ascendis Pharma A/S position peaked at $2.16M in Q4 2019.
185 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q4 2023.

Based on Credit Suisse's 13F filing for Q4 2023, filed 8 Feb 2024.